# # # #
In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020.
Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who feel left out – and the contents should certainly not be considered definitive or exhaustive.
It was just some of the stuff that made me say “wow” in 2020.
And in the next SoPD post, we will conduct our annual horizon scan and consider what 2021 may have in store for us.
# # # #
More than any other year, 2020 saw the best and worst of us.
It was a ridiculous 365 days (you couldn’t make up half the stuff that happened – e.g. “bleach”), and also one of the most humbling periods of our lives. In many ways we came together and stepped up to face challenges (e.g. the COVID-19 vaccine efforts), and yet at that same time if you listen to any of the 24-hour idiotic noise we have never been so divided. Some of people showed tremendous courage (e.g. the front line medics), and others of us were found to be wanting and learnt how little (if any) fortitude we truly have.
It was a dreadful year, but at the same time one that has been strangely fascinating to experience.
And despite the setbacks brought on by the COVID-19 situation, there has been remarkable progress in the arena of Parkinson’s research and in today’s post we will do both a short and long review of 2020, according to research-related events/publications that we here at the SoPD thought were of note.
THE SHORT REVIEW: A top five
If we had to select a top 5 Parkinson’s research-related events/highlights of 2020, they would be: